The hypothesis that SARS-CoV-2 affects male reproductive ability by regulating autophagy

Copyright © 2020 Elsevier Ltd. All rights reserved..

The outbreak of CoronaVirus Disease19 (COVID19) in December 2019 posed a serious threat to public safety, and its rapid spread caused a global health emergency. Clinical data show that in addition to respiratory system damage, some male patients with COVID-19 are also accompanied by abnormal renal function and even renal damage. As the main receptor of syndrome coronavirus 2 (SARS-CoV-2), angiotensin converting enzyme 2 (ACE2) is also found to be highly expressed not only in respiratory mucosa and alveolar epithelial cells, but also in renal tubule cells, testicular Leydig cells and seminiferous tubule cells. This suggests that SARS-CoV-2 has the possibility of infecting the male reproductive system, and the recent detection of SARS-CoV-2 in the patient's semen further confirms this theory. In previous studies, it has been found that ACE2 has the ability to regulate autophagy. Not only that, recent studies have also found that SARS-CoV-2 infection can also lead to a reduction in autophagy. All of these associate SARS-CoV-2 with autophagy. Furthermore, autophagy has been shown to have an effect on male reproduction in many studies. Based on these, we propose the hypothesis that SARS-CoV-2 affects male reproductive function by regulating autophagy. This hypothesis may provide a new idea for future treatment of COVID-19 male patients with reproductive function injury, and it can also prompt medical staff and patients to consciously check their reproductive function.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:143

Enthalten in:

Medical hypotheses - 143(2020) vom: 26. Okt., Seite 110083

Sprache:

Englisch

Beteiligte Personen:

Sun, Jun [VerfasserIn]

Links:

Volltext

Themen:

ACE2
ACE2 protein, human
Angiotensin-Converting Enzyme 2
Autophagy
EC 3.4.15.1
EC 3.4.17.23
Journal Article
Peptidyl-Dipeptidase A
Reproduction
SARS-CoV-2

Anmerkungen:

Date Completed 13.10.2020

Date Revised 29.03.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.mehy.2020.110083

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM312557604